We also observed a correlation of Cdx2 positivity with lower (I+II) clinical stage, better histologic differentiation, and lower rate of vascular invasion and lymph node metastasis. This evidence concerns the gene CDX2 and metastatic malignant neoplasm in the lymph nodes.